Start Submission Become a Reviewer

Reading: Erythropoietn; A rare culprit of anemia in chronic kidney disease

Download

A- A+
Alt. Display

Case Reports

Erythropoietn; A rare culprit of anemia in chronic kidney disease

Authors:

Piratheepan Navaradnam ,

teaching hospital jaffna, LK
X close

Thirunavukarasu Kumanan,

university of Jaffna, LK
X close

Thaneshwary Sooriyakumar

teaching hospital jaffna, LK
X close

Abstract

Erythropoietin-induced antibody-mediated pure red cell aplasia is a rare and unexpected devastating adverse effect of erythropoietin analog. Patient and product-related factors, along with factors related to storage, determine the immunogenicity of erythropoietin. Early identification and withdrawal of erythropoietin with immunosuppressive therapy would improve the outcome. Here we present a 69-year-old male with chronic kidney disease treated with erythropoietin, had refractory anemia due to antibody-mediated pure redcell aplasia.
How to Cite: Navaradnam, P., Kumanan, T. and Sooriyakumar, T., 2021. Erythropoietn; A rare culprit of anemia in chronic kidney disease. Journal of the Postgraduate Institute of Medicine, 8(1), pp.E141 1–5. DOI: http://doi.org/10.4038/jpgim.8319
Published on 30 Jun 2021.
Peer Reviewed

Downloads

  • PDF (EN)

    comments powered by Disqus